OPKO Health Inc OPK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OPK is a good fit for your portfolio.
News
-
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
-
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
-
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
-
NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
-
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
-
Thinking about buying stock in Intuitive Machines, OPKO Health, Ardelyx, AXT Inc, or Clearmind Medicine?
-
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
-
NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China
Trading Information
- Previous Close Price
- $1.26
- Day Range
- $1.24–1.31
- 52-Week Range
- $0.85–2.24
- Bid/Ask
- $1.23 / $1.24
- Market Cap
- $864.27 Mil
- Volume/Avg
- 4.2 Mil / 8.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.08
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,930
- Website
- https://www.opko.com
Comparables
Valuation
|
Metric
|
OPK
|
TIHE
|
LNTH
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 11.50 |
Price/Book Value | 0.69 | — | 5.65 |
Price/Sales | 1.08 | — | 3.64 |
Price/Cash Flow | — | — | 9.92 |
Price/Earnings
OPK
TIHE
LNTH
Financial Strength
|
Metric
|
OPK
|
TIHE
|
LNTH
|
|---|---|---|---|
Quick Ratio | 1.13 | — | 5.33 |
Current Ratio | 1.55 | — | 5.80 |
Interest Coverage | −12.94 | — | 20.55 |
Quick Ratio
OPK
TIHE
LNTH
Profitability
|
Metric
|
OPK
|
TIHE
|
LNTH
|
|---|---|---|---|
Return on Assets (Normalized) | −7.81% | — | 30.46% |
Return on Equity (Normalized) | −11.03% | — | 73.91% |
Return on Invested Capital (Normalized) | −8.74% | — | 36.79% |
Return on Assets
OPK
TIHE
LNTH
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Gswwwqng | Fgwq | $220.2 Bil | |
DHR
| Danaher Corp | Yhndvfqjdc | Gzwfflz | $182.8 Bil | |
IQV
| IQVIA Holdings Inc | Cwgmjhzl | Lvdvz | $42.9 Bil | |
IDXX
| IDEXX Laboratories Inc | Pjgvpphsr | Cxsnwb | $42.0 Bil | |
A
| Agilent Technologies Inc | Bxqntvlmp | Ypfyb | $40.9 Bil | |
MTD
| Mettler-Toledo International Inc | Mkcmtvnprq | Mglwx | $26.8 Bil | |
ICLR
| Icon PLC | Ynzrlspp | Cysmzx | $25.1 Bil | |
ILMN
| Illumina Inc | Wmvkrlxt | Vztbj | $19.9 Bil | |
WAT
| Waters Corp | Wkcmjlbsr | Xvxfn | $18.7 Bil | |
LH
| Laboratory Corp of America Holdings | Shrvwcwjl | Jxkcdn | $17.2 Bil |